FeesSafety
Pluang+

P2Pool V2 runs on Bitcoin testnet, decentralizing mining verification and payouts for miners.

Protocol Fundamentals
15 Nov 2026, 19:42 WIB
Tokenpost
View Source
Bullish
P2Pool V2 runs on Bitcoin testnet, decentralizing mining verification and payouts for miners.

P2Pool V2 is a new protocol operating on Bitcoin's testnet that decentralizes the verification of mining work and earnings accounting by shifting these tasks from centralized pool operators to individual nodes. This reduces the control pool operators have over transaction selection, share accounting, and payouts, aiming to empower miners with permissionless mining and direct payouts that keep Bitcoin in their custody. Planned features include tradable mining shares and atomic swaps via Lightning and Ark to help smaller miners receive payments more efficiently. The protocol also supports variable difficulty and reduces losses from orphaned shares, with ongoing development for share trading and mainnet deployment.

P2Pool V2 on Bitcoin testnet is the subject, with Pluang market data showing 16 out of 50 major cryptocurrencies rose while 33 fell. Notable movers include SXP (Solar) down 46.27% at Rp37, ZIL (Zilliqa) down 14.83% at Rp22 with a 31% sell and 69% buy split, and BAL (Balancer) up 11.14% at Rp16.297. This snapshot is as of Nov 16, 2026 00:21 WIB.

More News

Aero (AERO) plunges 27% in a week, underperforming Bitcoin and Ether losses.

Aero (AERO) plunges 27% in a week, underperforming Bitcoin and Ether losses.

Over the past week, the cryptocurrency Aero (AERO) experienced a significant drop of 27%, which is a larger decline compared to the losses seen in major cryptocurrencies Bitcoin (BTC) and Ether (ETH). This sharp decrease highlights increased volatili...

Market News
Bearish
5 hours ago
CVS says GLP-1 drugs could save health plans if priced below $350 monthly by reducing hospital visits.

CVS says GLP-1 drugs could save health plans if priced below $350 monthly by reducing hospital visits.

CVS Health's analysis of Aetna insurance data shows that GLP-1 drugs, used for obesity and diabetes, could help employers and health plans break even if priced under $350 per month. These drugs reduce emergency room visits by 10%-12% and hospitalizat...

Market News
Neutral
5 hours ago
74% of VK2735-treated patients improved BMI category and cardiometabolic health after 13 weeks in Phase 2 trial

74% of VK2735-treated patients improved BMI category and cardiometabolic health after 13 weeks in Phase 2 trial

Viking Therapeutics reported that 74% of participants receiving weekly subcutaneous VK2735 improved by at least one BMI category after 13 weeks, with no patients experiencing BMI worsening. The Phase 2 VENTURE trial also showed significant improvemen...

Company Fundamentals
Bullish
6 hours ago
AMG TimesSquare Small Cap Growth Fund beats Russell 2000 Growth Index in Q3 2026 with strong sector performance.

AMG TimesSquare Small Cap Growth Fund beats Russell 2000 Growth Index in Q3 2026 with strong sector performance.

In Q3 2026, AMG TimesSquare Small Cap Growth Fund outperformed the Russell 2000® Growth Index, driven by strong holdings in Information Technology, Financials, and Consumer Staples sectors. The fund's success was attributed to company-specific fundam...

Market News
Bullish
6 hours ago
Schwab US Dividend Equity ETF rallies 10% on strong earnings and dividend inflows, with 8% upside potential.

Schwab US Dividend Equity ETF rallies 10% on strong earnings and dividend inflows, with 8% upside potential.

The Schwab US Dividend Equity ETF (SCHD) has rallied about 10% since early October, supported by stronger earnings from key holdings like Texas Instruments and UnitedHealth, as well as inflows into dividend-focused funds. SCHD trades at roughly 18.6 ...

Market News
Bullish
6 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App